Adjunctive basal GLP-1-RA therapy in patients after MBS may be a promising treatment choice in weight management in addition to lifestyle changes, not only due to increased GLP-1 signaling, but also to a putative blunting effect on metabolic adaptation that occurs after MBS, increased fat oxidation, and decreased carbohydrate and protein oxidation
Ozempic (semaglutide) is a GLP-1 receptor agonist that regulates blood glucose and suppresses appetite, whilst cannabis affects multiple body systems including metabolism, gastrointestinal function, and cardiovascular health
4/23/2026 Jason T Great for Appetite Control Without Stimulants Sold and shipped by Sabaforlife.com I specifically wanted something to help with appetite control, but I cannot tolerate caffeine or harsh fat burners
Saxenda nie powinna by stosowana z innymi lekami wpywajcymi na receptory GLP-1
The best path forward with semaglutide is to work with a knowledgeable healthcare provider who can help you find the right dosage where you can see results but also minimize side effects